Prevention of type 2 diabetes: the Finnish experience
DOI:
https://doi.org/10.1002/edn.92Keywords:
Prevention, population strategy, high risk strategy, screening, early diagnosis, interventions, evaluationAbstract
AbstractPrevention is nowadays an acknowledged part of health care. Type 2 diabetes is a costly disease with severe complications and its prevalence is increasing on a global scale. Several studies show that type 2 diabetes can be prevented and changes in lifestyle are effective.
Finland was the first country in the world that started a national prevention programme. The implementation of the programme is called FIN-D2D Project and it started 2003. The first part of it will be finished by the end of the year 2007.
FIN-D2D Project was first started in five hospital districts and the population in those districts is 1.5 million inhabitants. The Prevention Project influences health through three strategies: a population strategy, a high risk strategy and by early diagnosis and management. The main focus of the programme is on high risk strategy and screening. To prevent type 2 diabetes it is essential to find those people at high risk as soon as possible and to provide information and initiate appropriate interventions.
The new challenges for health care professionals working in the prevention project have been careful planning and co-operation with community sector and decision-makers. Group education has become an important part of education.
The effectiveness, cost-effectiveness and feasibility of the programme have been estimated and the evaluation will be published during the year 2008. If the results are positive the aim is to make prevention of type 2 diabetes a permanent part of primary and occupational health care practises.
Downloads
References
Kangas T. The consumption and direct costs of health care services among per-sons with diabetes in Helsinki. Social Insurance Institution. Studies in Social Security and Health 67/2002.
Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng j Med 2001; 344: 1343–1350.
Knowler WC, Barret-Connor E, Fowler SE, et al. Reduction in the evidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med 2002; 346: 393–403.
Development Programme for the Prevention and Care of Diabetes in Finland 2001–2010. The Finnish Diabetes Association, 2001.
Programme for the Prevention of Type 2 Diabetes in Finland 2003–2010. The Finnish Diabetes Association, 2003. http://www.diabetes.fi/english/prevention/programme/index.html. [Accessed 11 July 2007].
Implementation of type 2 diabetes. Prevention Plan. Project Plan 2003–2007. FIN-D2D Project. The Finnish Diabetes Association, 2006.
Diabetes Risk Test: http://www.diabetesii/english/risktest/ [Accessed 11 July 2007].
Lindstrom J, Tuomilehto J. The Diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725–731.
The DECODE Study Group (2001). Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161: 397–405.
One Small Decision a Day Project 2000–2003. Finnish DiabetesAssociation and Finnish Heart Association.
Heinonen K, Heinonen L. Group training provides new stimulus for preven-tion of metabolic syndrome (In Finnish). The Finnish Diabetes Association. Diabetes and Doctor 1/2000. Report of DELHKO 2005: 7. http:www.diabetes.fi/DELHKO/julkaisut [Accessed 11 July 2007].
Prochaska JO, Velicer WF. The transthe-oretical model of health behaviour change. Am J Healt Promot 1997; 12: 38–48.
Lindstrom J. Prevention of type 2 diabetes with lifestyle intervention emphasis on dietary composition and identification of high-risk individuals. Publications of the National Public Health Institute 18/2006
DEHKO Proceedings 2005–2007. The Finnish Diabetes Association. http:www.diabetes.fi/english [Accessed 11 July 2007].
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2007 Copyright © 2007 FEND.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.